Overexpression of TG-Interacting Factor Is Associated with Worse Prognosis in Upper Urinary Tract Urothelial Carcinoma

被引:29
|
作者
Yeh, Bi-Wen [1 ,2 ]
Wu, Wen-Jeng [3 ,4 ,5 ]
Li, Wei-Ming [3 ,4 ]
Li, Ching-Chia [3 ,4 ]
Huang, Chun-Nung [4 ]
Kang, Wan-Yi [6 ]
Liu, Zi-Miao [1 ]
Huang, Huei-Sheng [6 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 701, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 701, Taiwan
[3] Kaohsiung Med Univ Hosp, Coll Med, Grad Inst Med, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ Hosp, Fac Med, Coll Med, Dept Urol, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Urol, Kaohsiung, Taiwan
[6] Kuo Gen Hosp, Dept Pathol, Tainan, Taiwan
关键词
TRANSITIONAL-CELL CARCINOMA; BLADDER-CANCER; RADICAL NEPHROURETERECTOMY; CHROMOSOMAL IMBALANCES; MATRIX DEGRADATION; GENE-EXPRESSION; INVADOPODIA; PROTEIN; P21; PROGRESSION;
D O I
10.1016/j.ajpath.2012.05.024
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Prognostic outcome prediction would be useful for the treatment of patients with upper urinary tract urothelial carcinoma (UC). However, its prognostic biomarkers are not well established so far. According to the results of analysis of 168 human upper urinary tract UC specimens, overexpressed TG-interacting factor (TGIF) in nuclei of tumor tissues is significantly correlated with poor progression-free survival and higher cancer-related death. When both TGIF and p21 expression are altered, these patients had an even worse prognosis than those with one or no marker altered. Furthermore, to elucidate the role of TGIF in the progression of UC, overexpression of TGIF in RT4 or TSGH8301 cells was performed, and the results revealed that TGIF can significantly increase migration/invasion ability, matrix metalloproteinase expression, and invadopodia formation via the phosphatidylinositol 3-kinase-AKT pathway. In contrast, knockdown of TGIF with its specific short hairpin RNA inhibited the invasion ability of T24 cells. Besides, TGIF could inhibit p21(WAF/CIP1) expression, up-regulate cyclin D1 expression, and phosphorylate retinoblastoma to promote G1-S transition and cellular proliferation. In conclusion, we demonstrated that TGIF contributes to the progression of urothelial carcinoma via the phosphatidylinositol 3-kinase-AKT pathway. It may serve as an attractive therapeutic or prognostic target for selected patients with upper urinary tract UC. (Am J Pathol 2012, 181:1044-1055; http://dx.doi.org/10.1016/j.ajpath.2012.05.024)
引用
收藏
页码:1044 / 1055
页数:12
相关论文
共 50 条
  • [1] Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma
    Ke, Hung-Lung
    Chang, Lin-Li
    Yang, Sheau-Fang
    Lin, Hui-Hui
    Li, Ching-Chia
    Wu, Deng-Chyang
    Wu, Wen-Jeng
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (06) : 703 - 709
  • [2] Peripelvic/periureteral fat invasion is independently associated with worse prognosis in pT3 upper tract urothelial carcinoma
    Park, Jinsung
    Park, Sejun
    Song, Cheryn
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    WORLD JOURNAL OF UROLOGY, 2014, 32 (01) : 157 - 163
  • [3] Squamous differentiation and prognosis in upper urinary tract urothelial carcinoma
    Makise, Naohiro
    Morikawa, Teppei
    Kawai, Taketo
    Nakagawa, Tohru
    Kume, Haruki
    Homma, Yukio
    Fukayama, Masashi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 7203 - 7209
  • [4] Ureteral and Multifocal Tumours Have Worse Prognosis than Renal Pelvic Tumours in Urothelial Carcinoma of the Upper Urinary Tract Treated by Nephroureterectomy
    Ouzzane, Adil
    Colin, Pierre
    Xylinas, Evanguelos
    Pignot, Geraldine
    Ariane, Mehdi Mokhtar
    Saint, Fabien
    Hoarau, Nicolas
    Adam, Emilie
    Azemar, Marie Dominique
    Bensadoun, Henri
    Cormier, Luc
    Cussenot, Olivier
    Houlgatte, Alain
    Karsenty, Gilles
    Bruyere, Franck
    Maurin, Charlotte
    Nouhaud, Francois Xavier
    Phe, Veronique
    Polguer, Thomas
    Roumiguie, Mathieu
    Ruffion, Alain
    Roupret, Morgan
    EUROPEAN UROLOGY, 2011, 60 (06) : 1258 - 1265
  • [5] TG-interacting factor-induced superoxide production from NADPH oxidase contributes to the migration/invasion of urothelial carcinoma
    Huang, Huei-Sheng
    Liu, Zi-Miao
    Chen, Pei-Chi
    Tseng, Hong-Yu
    Yeh, Bi-Wen
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (04) : 769 - 778
  • [6] HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)
    Soria, Francesco
    Moschini, Marco
    Haitel, Andrea
    Wirth, Gregory J.
    Karam, Jose A.
    Wood, Christopher G.
    Roupret, Morgan
    Margulis, Vitaly
    Karakiewicz, Pierre I.
    Briganti, Alberto
    Raman, Jay D.
    Kammerer-Jacquet, Solene-Florence
    Mathieu, Romain
    Bensalah, Karim
    Lotan, Yair
    Oezsoy, Mehmet
    Remzi, Mesut
    Gust, Kilian M.
    Shariat, Shahrokh F.
    WORLD JOURNAL OF UROLOGY, 2017, 35 (02) : 251 - 259
  • [7] Treatment of upper urinary tract urothelial carcinoma
    Cai, Guiyang
    Liu, Xuefeng
    Wu, Bin
    SURGICAL ONCOLOGY-OXFORD, 2011, 20 (01): : 43 - 55
  • [8] Urothelial carcinoma of the upper urinary tract
    Kranz, Jennifer
    Hoffmann, Marco
    Alexa, Radu
    Kuppe, Christoph
    Gaisa, Nadine Therese
    Saar, Matthias
    UROLOGIE, 2023, 62 (06): : 640 - 650
  • [9] Prognostic factors for upper urinary tract urothelial carcinoma
    Chromecki, Thomas F.
    Bensalah, Karim
    Remzi, Mesut
    Verhoest, Gregory
    Cha, Eugene K.
    Scherr, Douglas S.
    Novara, Giacomo
    Karakiewicz, Pierre I.
    Shariat, Shahrokh F.
    NATURE REVIEWS UROLOGY, 2011, 8 (08) : 440 - 447
  • [10] Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
    Chang, I-Wei
    Wang, Yu-Hui
    Wu, Wen-Jeng
    Liang, Peir-In
    Li, Wei-Ming
    Yeh, Bi-Wen
    Wu, Ting-Feng
    He, Hong-Lin
    Huang, Steven Kuan-Hua
    Li, Chien-Feng
    JOURNAL OF CANCER, 2016, 7 (03): : 304 - 313